xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2391 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAA | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207568 | 417 | Table 4 | Positive-Low | true | 1600.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2391 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAA | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207564 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2393 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAC | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207570 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2393 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAC | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207572 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2393 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAC | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207569 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2393 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAC | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207573 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2393 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAC | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207574 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2393 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAC | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207571 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207578 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207580 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207576 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207577 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207575 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207579 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2395 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAG | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207582 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2395 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAG | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207581 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2395 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAG | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207584 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2395 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAG | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207585 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2395 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAG | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207586 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2395 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAG | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207583 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2396 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207589 | 417 | Table 4 | Positive-High | true | 27.1 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2396 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207587 | 417 | Table 4 | Positive-High | true | 27.8 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2396 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207588 | 417 | Table 4 | Positive-High | true | 14.9 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2396 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207592 | 417 | Table 4 | Positive-Intermediate | true | 105.3 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2396 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207591 | 417 | Table 4 | Positive-High | true | 37.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2396 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAI | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207590 | 417 | Table 4 | Positive-High | true | 39.1 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2397 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207593 | 417 | Table 4 | Positive-Intermediate | true | 125.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2397 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207594 | 417 | Table 4 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2397 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207597 | 417 | Table 4 | Positive-High | true | 43.6 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2397 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207595 | 417 | Table 4 | Positive-High | true | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2397 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207596 | 417 | Table 4 | Positive-High | true | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2397 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207598 | 417 | Table 4 | Positive-Intermediate | true | 153.9 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2398 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207600 | 417 | Table 4 | Positive-High | true | 23.9 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2398 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207599 | 417 | Table 4 | Positive-Intermediate | true | 200.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2398 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207601 | 417 | Table 4 | Positive-Intermediate | true | 322.6 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2398 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207602 | 417 | Table 4 | Positive-Intermediate | true | 87.8 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2398 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207604 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2398 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207603 | 417 | Table 4 | Positive-Intermediate | true | 108.9 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2399 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAN | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207609 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2399 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAN | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207610 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2399 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAN | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207605 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2399 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAN | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207606 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2399 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAN | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207608 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2399 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAN | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207607 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2400 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207616 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2400 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207611 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2400 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207614 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2400 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207615 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2400 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207613 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2400 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAP | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207612 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2401 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAR | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207619 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2401 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAR | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207621 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2401 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAR | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207620 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2401 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAR | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207622 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2401 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAR | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207618 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2401 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAR | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207617 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2402 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAS | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207627 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2402 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAS | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207624 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2402 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAS | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207628 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2402 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAS | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207625 | 417 | Table 4 | Positive-Low | true | 909.1 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2402 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAS | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207623 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2402 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAS | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207626 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2403 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207634 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2403 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207630 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2403 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207632 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2403 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207633 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2403 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207629 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2403 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAT | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207631 | 417 | Table 4 | Positive-Intermediate | true | 232.6 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207638 | 417 | Table 4 | Positive-High | true | 5.9 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207645 | 417 | Table 3 | Positive-Low | true | 3636.3635 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207635 | 417 | Table 3 | Positive-High | true | 5.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207639 | 417 | Table 3 | Positive-High | true | 45.5 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207641 | 417 | Table 3 | Positive-High | true | 5.6 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207642 | 417 | Table 4 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207644 | 417 | Table 4 | Positive-High | true | 3.7 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207637 | 417 | Table 3 | Positive-High | true | 4.7 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207640 | 417 | Table 4 | Positive-High | true | 50.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207646 | 417 | Table 4 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207643 | 417 | Table 3 | Positive-High | true | 7.6 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2405 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207647 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2405 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207648 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2405 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207650 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2405 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1008020 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2405 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1008021 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 2405 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207649 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3224 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ANAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207658 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3224 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ANAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207659 | 417 | Table 3 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3224 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ANAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207661 | 417 | Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3224 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ANAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207662 | 417 | Table 3 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3224 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ANAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207657 | 417 | Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3224 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ANAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207660 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3479 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207663 | 417 | Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3479 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207664 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3479 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207665 | 417 | Table 3 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3479 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207667 | 417 | Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3479 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207668 | 417 | Table 3 | Positive-Low | true | 2500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 3479 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | APAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207666 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4316 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ASAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207670 | 417 | Table 3 | Positive-High | true | 35.9 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4316 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ASAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207672 | 417 | Table 3 | Positive-Intermediate | true | 391.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4316 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ASAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207673 | 417 | Table 3 | Positive-Intermediate | true | 148.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.